- Q1 2024 SpringWorks Therapeutics Inc Earnings Call TranscriptMay 02, 2024$43.35 (-7.45%)Earnings
- SpringWorks Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 08, 2024
- SpringWorks Therapeutics to Discuss The ReNeu Topline Data TranscriptNov 16, 2023
- SpringWorks Therapeutics Inc at Goldman Sachs Healthcare Conference TranscriptJun 12, 2023
- SpringWorks Therapeutics Inc at TD Cowen Oncology Innovation Summit (Virtual) TranscriptMay 31, 2023
- SpringWorks Therapeutics Inc at Bank of America Global Healthcare Conference TranscriptMay 09, 2023
- SpringWorks Therapeutics Inc at Cowen Health Care Conference TranscriptMar 07, 2023
- SpringWorks Therapeutics Inc at JPMorgan Healthcare Conference TranscriptJan 09, 2023
- SpringWorks Therapeutics Inc at Evercore ISI HealthCONx Conference (Virtual) TranscriptNov 29, 2022
- SpringWorks Therapeutics Inc at H.C. Wainwright Precision Oncology Conference (Virtual) TranscriptNov 14, 2022
- SpringWorks Therapeutics Inc at Goldman Sachs Global Healthcare Conference TranscriptJun 15, 2022
- SpringWorks Therapeutics Inc R&D Day (Virtual) TranscriptJun 10, 2022
- SpringWorks Therapeutics Inc To Discuss The DeFi Trial Data Call TranscriptMay 24, 2022
- SpringWorks Therapeutics Inc at Guggenheim Partners Healthcare Talks Oncology Days (Virtual) TranscriptFeb 10, 2022
- SpringWorks Therapeutics Inc and the ReNeu Trial for NF1-Related Plexiform Neurofibromas TranscriptJul 15, 2021
- SpringWorks Therapeutics Inc at Goldman Sachs Global Healthcare Conference (Virtual) TranscriptJun 08, 2021
- SpringWorks Therapeutics to Discuss the Reneu Trial Data and Program Update Call TranscriptFeb 25, 2021
- SpringWorks Therapeutics Inc at JPMorgan Healthcare Conference (Virtual) TranscriptJan 12, 2021
- SpringWorks Therapeutics Inc Clinical Trials TranscriptOct 13, 2020
SpringWorks Therapeutics Inc at JPMorgan Healthcare Conference Transcript
All right. Welcome, everybody, to the 42nd Annual JPMorgan Healthcare Conference. My name is Anupam Rama. I'm one of the senior biotech analysts here at JPMorgan. I'm joined by the team, Malcolm Kuno, Priyanka Grover, and LaRhea Hall. I want to kick off Monday morning with the SpringWorks, and speaking on behalf of the company, we have CEO, Saqib Islam. Saqib?
Thanks, Anupam. It's a pleasure to be here as always, and we appreciate you and the JPMorgan team hosting us.
Before we begin, I'll remind everyone that today's presentation includes some forward-looking statements. So at SpringWorks, we develop therapies that can meaningfully improve the lives of patients with severe rare diseases and cancer. With the recent FDA approval of Ogsiveo, we are proud to be executing on our commitment to patients and their families. Beyond Ogsiveo, we believe that we have best-in-class data with mirdametinib, our MEK inhibitor that could support a second product approval for patients
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust.png)